No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs115502602 |
chr6:5694680-5694681 |
Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs183283257 |
chr6:5694681-5694682 |
Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs559882420 |
chr6:5694709-5694710 |
Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs12215495 |
chr6:5694713-5694714 |
Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs548821073 |
chr6:5694730-5694731 |
Weak transcription Flanking Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs185688538 |
chr6:5694812-5694813 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs537845008 |
chr6:5694836-5694837 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs550274714 |
chr6:5694837-5694838 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs561016056 |
chr6:5694854-5694855 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs11969885 |
chr6:5694930-5694931 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs539099306 |
chr6:5694934-5694935 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs554426492 |
chr6:5694991-5694992 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs572623722 |
chr6:5695007-5695008 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs536954647 |
chr6:5695025-5695026 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs78838161 |
chr6:5695066-5695067 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs79583631 |
chr6:5695076-5695077 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs71540880 |
chr6:5695077-5695078 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs140751544 |
chr6:5695084-5695085 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs61210395 |
chr6:5695090-5695091 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs113708035 |
chr6:5695111-5695112 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs11752777 |
chr6:5695126-5695127 |
Weak transcription Enhancers Strong transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
22 |
rs190496063 |
chr6:5695128-5695129 |
Weak transcription Enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs544677856 |
chr6:5695137-5695138 |
Weak transcription Enhancers Strong transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|